Amina Jumamyradova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Amina Jumamyradova has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Alexey Aleksandrovich Soshnev
Department of Neuroscience, Developmental and Regenerative Biology, The University of Texas at San Antonio, San Antonio, Texas, 78249, USA
3 shared publications - Dustin R. Fetch
Graduate Program in Developmental and Regenerative Sciences, The University of Texas at San Antonio, San Antonio, Texas, 78249, USA
2 shared publications - Cameron M Chapa
Developmental and Regenerative Biology, The University of Texas at San Antonio Department of Neuroscience One UTSA Circle, San Antonio, TX 78249
1 shared publication Cameron M. Chapa
Department of Neuroscience, Developmental and Regenerative Biology, The University of Texas at San Antonio, San Antonio, TX 78249, USA
1 shared publication- Creehan Healy1 shared publication
- Harry Siegel1 shared publication
Latest Publications
- Open Access
- 5 August 2025
- Published by Elsevier in Data in Brief
- Vol. 62, 111957
RNA-Seq dataset of wild type and PRC2 mutant mouse embryonic stem cells undergoing ground state conversion
- 5 August 2025
- Published by Elsevier in Data in Brief
- Vol. 62, 111957
Open AccessRNA-Seq dataset of wild type and PRC2 mutant mouse embryonic stem cells undergoing ground state conversion
- Open Access
- 11 July 2025
- Published by Oxford University Press (OUP) in NAR Molecular Medicine
- Vol. 2 (3)
Aere perennius: how chromatin fidelity is maintained and lost in disease
Multicellular organisms arise from a single genome template in the zygote, necessitating the cells of the developing embryo to up- and downregulate specific genes to establish and maintain their identity. This template is maintained, propagated, and interpreted as chromatin, a polymer of nucleic acids and associated structural and regulatory proteins. Recent genome-wide surveys documented a wealth of disease-associated mutations in chromatin factors, indicating their fundamental significance and potential for therapeutic targeting. However, chromatin factors exist in a complex balance, with a single deficiency often leading to pleiotropic downstream effects. Here, we review the mechanisms of chromatin regulation and partitioning, highlighting examples of how these processes are altered in human diseases. We argue that loss of chromatin fidelity, both locally at specific genes and regulatory elements, and globally at the megabase-scale, contributes to many pathological states and may thus represent an intriguing target for corrective interventions.
- 11 July 2025
- Published by Oxford University Press (OUP) in NAR Molecular Medicine
- Vol. 2 (3)
Open AccessAere perennius: how chromatin fidelity is maintained and lost in disease
Multicellular organisms arise from a single genome template in the zygote, necessitating the cells of the developing embryo to up- and downregulate specific genes to establish and maintain their identity. This template is maintained, propagated, and interpreted as chromatin, a polymer of nucleic acids and associated structural and regulatory proteins. Recent genome-wide surveys documented a wealth of disease-associated mutations in chromatin factors, indicating their fundamental significance and potential for therapeutic targeting. However, chromatin factors exist in a complex balance, with a single deficiency often leading to pleiotropic downstream effects. Here, we review the mechanisms of chromatin regulation and partitioning, highlighting examples of how these processes are altered in human diseases. We argue that loss of chromatin fidelity, both locally at specific genes and regulatory elements, and globally at the megabase-scale, contributes to many pathological states and may thus represent an intriguing target for corrective interventions.
- Open Access
Juvenile hormone degradation enzymes have shared and unique requirements in Drosophila development
Precise control of hormones is essential to development and reproduction. Hormone bioavailability is regulated by their synthesis and transport, as well as sequestration, natural turnover, and programmed degradation. Here, we use Drosophila melanogaster to investigate developmentally programmed degradation of the retinoic acid-like Juvenile hormones (JHs) that functionally oppose the steroid hormone, ecdysone. Elevated JH titers promote growth and prevent metamorphosis. To understand the role of programmed JH degradation, we generated double and triple knockout animals lacking one of two classes of JH degradation enzymes: JH esterases (JHEs) and JH epoxide hydrolases (JHEHs). While both classes of enzymes degrade JHs, we found they have separate developmental functions such that JHEs restrain growth while JHEHs support growth and ensure timely metamorphosis. To investigate the nature of these unique developmental requirements, we performed genetic and hormone rescue experiments, analyzed hormone-producing glands, and characterized dysregulated gene networks by RNA-sequencing. Together, these data revealed unique dysregulated networks consistent with the separate developmental requirements, as well as shared regulation of Cytochrome P450 gene expression and the size of the ecdysone-producing gland. Strikingly, the four-day delay in metamorphosis in the absence of JHEHs is rescued by ecdysone despite increased ecdysone synthesis gene expression and larger glands in these animals. Together, this study provides new genetic tools and insights into the complexities of programmed hormone degradation in development.
Open AccessJuvenile hormone degradation enzymes have shared and unique requirements in Drosophila development
Precise control of hormones is essential to development and reproduction. Hormone bioavailability is regulated by their synthesis and transport, as well as sequestration, natural turnover, and programmed degradation. Here, we use Drosophila melanogaster to investigate developmentally programmed degradation of the retinoic acid-like Juvenile hormones (JHs) that functionally oppose the steroid hormone, ecdysone. Elevated JH titers promote growth and prevent metamorphosis. To understand the role of programmed JH degradation, we generated double and triple knockout animals lacking one of two classes of JH degradation enzymes: JH esterases (JHEs) and JH epoxide hydrolases (JHEHs). While both classes of enzymes degrade JHs, we found they have separate developmental functions such that JHEs restrain growth while JHEHs support growth and ensure timely metamorphosis. To investigate the nature of these unique developmental requirements, we performed genetic and hormone rescue experiments, analyzed hormone-producing glands, and characterized dysregulated gene networks by RNA-sequencing. Together, these data revealed unique dysregulated networks consistent with the separate developmental requirements, as well as shared regulation of Cytochrome P450 gene expression and the size of the ecdysone-producing gland. Strikingly, the four-day delay in metamorphosis in the absence of JHEHs is rescued by ecdysone despite increased ecdysone synthesis gene expression and larger glands in these animals. Together, this study provides new genetic tools and insights into the complexities of programmed hormone degradation in development.